Dual agonist review | Rx required
Tirzepatide Pathway Review
About Tirzepatide Pathway Review
Could Mounjaro be the clinically advanced weight loss solution your body has been waiting for? The Tirzepatide Pathway Review at Yoyime Clinic in Dubai is a comprehensive, doctor-led assessment for patients considering treatment with tirzepatide, the dual GIP and GLP-1 receptor agonist that simultaneously activates two powerful incretin pathways to regulate appetite, satiety, gastric emptying, insulin secretion and glucose metabolism. Our doctor evaluates your medical history, weight-related health conditions, current medications and individual goals to confirm suitability before prescribing this DHA and MOHAP regulated prescription therapy. An individualized monitoring plan including structured dose escalation, regular clinical review and ongoing lifestyle support ensures maximum treatment effectiveness and safety throughout your entire Mounjaro weight loss journey at Yoyime Clinic.
Benefits of Tirzepatide Pathway Review
Assesses Mounjaro Suitability
Explains Benefits And Risks
Supports Personalized Dosing
Not Recommended for Patients
Who Are Pregnant
With Thyroid Cancer
With Severe Gastroparesis
Step-by-Step Procedure - Tirzepatide Pathway Review
Book Your Pathway Review
Schedule a Tirzepatide (Mounjaro®) Pathway Review at Yoyime Clinic as the first step before any prescription is considered.
Medical Assessment
Our doctor reviews your medical history, BMI, weight history, obesity-related health conditions, previous weight-loss treatments, current medications, allergies and family history to determine whether tirzepatide may be appropriate.
Clinical Eligibility Screening
Yoyime’s expert clinician evaluates potential indications, contraindications and any risk factors. Where clinically indicated, laboratory investigations may be recommended to assess metabolic health and confirm treatment suitability.
Tirzepatide Education
Our doctor will explain how Mounjaro® works through its dual GIP and GLP-1 receptor activity, discuss the expected rate of weight loss, review the dose-escalation schedule and explain possible side effects along with how they should be managed.
Personalised Treatment Decision
Based on your assessment, our doctor will decide if tirzepatide is suitable and recommend further testing if needed or will suggest an alternative medically supervised weight-management approach.
Ongoing Clinical Monitoring
If treatment begins, you will follow a structured programme of regular reviews to monitor weight-loss progress, treatment response, dose titration, tolerability and overall metabolic health.
Have questions about Tirzepatide Pathway Review?
Message our team on WhatsApp for personalised guidance before you book.
- Highly specialised and focused treatment techniques
- Personalised care by DHA certified professionals
- Comfort-driven experience with proven results
- Safe, convenient and effective
Frequently Asked Questions
Tirzepatide Pathway Review
The Tirzepatide (Mounjaro®) Pathway Review at Yoyime Clinic is a doctor-led consultation that determines whether treatment with tirzepatide is appropriate. It combines clinical assessment, eligibility screening, patient education and treatment planning before any prescription is issued.
Mounjaro® is the brand name for tirzepatide, a prescription medication belonging to the dual GIP/GLP-1 receptor agonist class. It works by activating two naturally occurring incretin hormone pathways involved in appetite regulation, blood sugar control, gastric emptying and energy metabolism.
Unlike medications containing semaglutide, which activate only the GLP-1 receptor, Mounjaro® stimulates both GIP and GLP-1 receptors. This dual mechanism may provide greater appetite suppression and improved metabolic effects for appropriately selected patients.
The pathway is intended for adults with overweight or obesity who may benefit from medically supervised weight management. Suitability depends on factors including BMI, obesity-related medical conditions, previous weight-loss attempts, current medications and overall health.
No. Mounjaro® is a prescription-only medicine regulated by the Dubai Health Authority (DHA) and MOHAP. At Yoyime Clinic, treatment is only prescribed following a comprehensive medical assessment confirming that it is clinically appropriate.
Depending on patient medical history and clinical assessment, our doctor may recommend blood tests to evaluate metabolic health, blood sugar regulation, liver and kidney function, thyroid function or other relevant biomarkers before treatment begins.
Our doctors will explain both common and less common side effects. The most frequently reported include nausea, vomiting, diarrhoea, constipation, reduced appetite and abdominal discomfort, particularly during the dose-escalation phase.
Tirzepatide treatment follows a structured titration schedule, beginning with a lower starting dose before gradually increasing over time. This approach helps improve tolerability and reduces the likelihood of gastrointestinal side effects while allowing your body to adapt to the medication.
If tirzepatide is not the most appropriate option, Yoyime Clinic will discuss alternative medically supervised weight-management strategies based on patients clinical assessment and treatment goals.
Once treatment begins, Yoyime Clinic provides structured clinical follow-up to monitor weight loss, appetite changes, treatment response, side effects and dose optimisation, ensuring that the therapy remains safe and effective throughout the programme.
Yes. The pathway is commonly combined with services such as metabolic blood testing, hormonal assessment, body composition analysis and ongoing weight-management monitoring to provide a comprehensive understanding of metabolic health before and during treatment.
At Yoyime Clinic, the focus extends beyond prescribing medication. Every patient undergoes a structured medical assessment, personalised eligibility screening and ongoing doctor-led monitoring to ensure Mounjaro® is prescribed safely, dose titration is carefully managed and treatment is integrated into a comprehensive, evidence-based weight management programme.
